Okla. Stat. tit. 63, § 63-5030.1

A. There is hereby created within the Oklahoma Health Care

Authority the Medicaid Drug Utilization Review Board, which shall be

responsible for the development, implementation and assessment of

retrospective and prospective drug utilization programs under the

direction of the Authority.

B. The Medicaid Drug Utilization Review Board shall consist of

ten (10) members appointed by the administrator of the Authority as

follows:

1. Four physicians, licensed and actively engaged in the

practice of medicine or osteopathic medicine in this state, of

which:

a. three shall be physicians chosen from a list of not

less than six names submitted by the Oklahoma State

Medical Association, and

b. one shall be a physician chosen from a list of not

less than two names submitted by the Oklahoma

Osteopathic Association;

2. Four licensed pharmacists actively engaged in the practice

of pharmacy, chosen from a list of not less than six names submitted

by the Oklahoma Pharmaceutical Association;

3. One person representing the lay community, who shall not be

a physician or a pharmacist, but shall be a health care professional

with recognized knowledge and expertise in at least one of the

following:

a. clinically appropriate prescribing of covered

outpatient drugs,

b. clinically appropriate dispensing and monitoring of

covered outpatient drugs,

c. drug use review, evaluation and intervention, and

d. medical quality assurance; and

Oklahoma Statutes - Title 63. Public Health and Safety Page 1732

4. One person representing the pharmaceutical industry who is a

resident of the State of Oklahoma, chosen from a list of not less

than two names submitted by the Pharmaceutical Research and

Manufacturers of America. The member representing the

pharmaceutical industry shall be prohibited from voting on action

items involving drugs or classes of drugs.

C. Members shall serve terms of three (3) years, except that

one physician, one pharmacist and the lay representative shall each

be initially appointed for two-year terms in order to stagger the

terms. In making the appointments, the administrator shall provide,

to the extent possible, for geographic balance in the representation

on the Medicaid Drug Utilization Review Board. Members may be

reappointed for a period not to exceed three three-year terms and

one partial term. Vacancies on the Medicaid Drug Utilization Review

Board shall be filled for the balance of the unexpired term from new

lists submitted by the entity originally submitting the list for the

position vacated.

D. The Medicaid Drug Utilization Review Board shall elect from

among its members a chair and a vice-chair who shall serve one-year

terms, provided they may succeed themselves.

E. The proceedings of all meetings of the Medicaid Drug

Utilization Review Board shall comply with the provisions of the

Oklahoma Open Meeting Act and shall be subject to the provisions of

the Administrative Procedures Act.

F. The Medicaid Drug Utilization Review Board may advise and

make recommendations to the Authority regarding existing, proposed

and emergency rules governing retrospective and prospective drug

utilization programs. The Oklahoma Health Care Authority Board

shall promulgate rules pursuant to the provisions of the

Administrative Procedures Act for implementation of the provisions

of this section.